Cargando…
Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway
INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is an orphan disease characterized by progressive loss of lung function resulting in shortness of breath and often death within 3–4 years of diagnosis. Repetitive lung injury in susceptible individuals is believed to promote chronic oxidative stress,...
Autores principales: | Ebrahimpour, Afshin, Wang, Min, Li, Li, Jegga, Anil G., Bonnen, Mark D., Eissa, N. Tony, Raghu, Ganesh, Jyothula, Soma, Kheradmand, Farrah, Hanania, Nicola A., Rosas, Ivan O., Ghebre, Yohannes T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136131/ https://www.ncbi.nlm.nih.gov/pubmed/34011367 http://dx.doi.org/10.1186/s12950-021-00284-6 |
Ejemplares similares
-
Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis
por: Ebrahimpour, Afshin, et al.
Publicado: (2022) -
Therapeutic Efficacy of Esomeprazole in Cotton Smoke-Induced Lung Injury Model
por: Nelson, Christina, et al.
Publicado: (2017) -
Esomeprazole enhances the effect of ionizing radiation to improve tumor control
por: Hebert, Kassidy A., et al.
Publicado: (2021) -
Silent Neoplastic Cardiac Invasion in Small Cell Lung Cancer: A Case Report and Review of the Literature
por: Pham, Ngoc, et al.
Publicado: (2018) -
Proton pump inhibitors and sensitization of cancer cells to radiation therapy
por: Hebert, Kassidy A., et al.
Publicado: (2022)